Aoxing Pharmaceutical Company, Inc. (AOXG)
| Market Cap | 1.02M |
| Revenue (ttm) | 30.11M |
| Net Income (ttm) | -1.46M |
| Shares Out | 76.21M |
| EPS (ttm) | -0.02 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Dividend Yield | n/a |
| Trading Day | January 15 |
| Last Price | $0.0066 |
| Previous Close | $0.0079 |
| Change ($) | -0.0013 |
| Change (%) | -16.46% |
| Day's Open | 0.0066 |
| Day's Range | 0.0066 - 0.0066 |
| Day's Volume | 6,000 |
| 52-Week Range | - |
News
There are no news available yet.
About AOXG
Aoxing Pharmaceutical Company a specialty pharmaceutical company, engages in research and development, manufacture, and distribution of narcotic, pain-management, and addiction treatment pharmaceutical products primarily in the People's Republic of China. The company's principal products include Zhongtong'an, a capsule of herbal extraction for the indication of oral and dental pain; and Yiqi Qiangshen Granule, an OTC herbal extraction for tonifying qi and empowering body, and promoting blood circulation to remove meridian obstruction, as well a... [Read more...]
| Industry Drug Manufacturers-Specialty & Generic | |
| CEO Zhenjiang Yue | Employees 346 |
| Stock Exchange OTCMKTS | Ticker Symbol AOXG |
Financial Performance
In 2016, AOXG's revenue was $32.33 million, an increase of 26.88% compared to the previous year's $25.48 million. Earnings were $2.06 million, a decrease of -62.49%.